South Africa is entering a new phase in its fight against HIV with the rollout of Lenacapavir, a long-acting HIV prevention medicine that health experts believe could transform efforts to reduce new infections. Writing on the significance of the breakthrough, Professor Nicholas Crisp said the medicine represents a major shift from prevention methods that rely…
Browsing: Lenacapavir
The United Nations has warned that nearly three million children could contract HIV by 2040, with more than half at risk of dying from AIDS-related illnesses if prevention and treatment efforts are not significantly expanded. The agency says the overwhelming majority of these infections are expected to occur in sub-Saharan Africa, where young people remain…
